Artemisinin and Derivatives Market to Reach $200 Million by 2025, Driven by Expanded Malaria Eradication Programs and Emerging Therapeutic Applications The global Artemisinin and Derivatives Market is ...

Artemisinin, a sesquiterpene lactone derived from Artemisia annua, has long been recognised for its antimalarial properties and is now under increasing scrutiny for its potential anticancer effects.

Novartis has won approval in Switzerland for the world’s first malaria drug for newborns and infants, creating a new weapon ...

The declaration of Suriname as the first malaria-free Amazonian country by the World Health Organization should spur other ...

Suriname became the first country in the Amazon region to receive malaria-free certification from the World Health ...

Suriname became the first country in the Amazon region to receive malaria-free certification from the World Health ...

Novartis and the non-profit Medicines for Malaria Venture (MMV) have advanced a novel drug combination for malaria into a phase 3 programme, raising hopes of a regimen that could be used to treat ...

Background Affordable medicines facility-malaria (AMFm) program and subsequently Co-payment mechanism were developed to help increase access to quality assured Artemisinin Combination Therapies (ACTs) ...

Bookmark stories for easy access on any device or the Swarajya app. Traditional and Modern Medicine Can and Must Co-exist. As modern medicine struggles with chronic illness and rising costs ...

Oxidative stress plays a key role in the pathogenesis of age-related macular degeneration (AMD), a leading cause of severe visual loss and blindness in the aging population which lacks any effective ...